No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates enhanced solid tumor eradication by nanobody-secreting CAR T cells in immunocompetent animal models, suggesting a strategy to counter tumor immunosuppression.
Xie et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: